DCF Advisers, LLC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
DCF Advisers, LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2022$23,000
-37.8%
25,1490.0%0.01%
-12.5%
Q1 2022$37,000
+42.3%
25,149
+107.0%
0.02%
+45.5%
Q4 2021$26,000
-39.5%
12,1490.0%0.01%
-42.1%
Q3 2021$43,00012,1490.02%
Other shareholders
ONCOCYTE CORP shareholders Q3 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 23,353,697$17,048,0001.30%
AWM Investment Company, Inc. 7,746,557$5,655,0000.86%
PURA VIDA INVESTMENTS, LLC 18,056,274$13,181,0000.76%
Defender Capital, LLC. 2,551,980$1,883,0000.74%
Penbrook Management LLC 563,350$411,0000.35%
ACT CAPITAL MANAGEMENT, LLC 330,000$241,0000.33%
CALIBER WEALTH MANAGEMENT, LLC 75,120$55,0000.04%
Fort Sheridan Advisors LLC 135,000$99,0000.03%
Orbimed Advisors 1,882,768$1,374,0000.03%
WEALTH EFFECTS LLC 51,000$37,0000.02%
View complete list of ONCOCYTE CORP shareholders